Fidia boosts equity as GGHL converts bonds into 1.8 million new shares

Fidia Spa ( (IT:FDA) ) has shared an update.

Fidia S.p.A. has converted nine bonds from the third tranche of its convertible bond loan with warrants, reserved for Global Growth Holding Limited, into 1.8 million new shares at a price of €0.05 per share. The new shares are immediately admitted to trading, increasing the company’s share capital by €90,000 to €10,437,761.90 and bringing the total number of shares outstanding to 37,542,927.

Following this transaction, the POC convertible loan has been subscribed for a nominal €750,000, with €590,000 of the related capital increase already subscribed and 16 bonds still outstanding and not yet converted. The move strengthens Fidia’s equity base and advances the gradual execution of its financing plan, potentially enhancing its financial flexibility to support operations in its core numerical control and integrated milling systems business.

The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.

More about Fidia Spa

Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global leader in high-performance integrated milling systems, numerical controls, and CAM software for complex shapes. Its solutions are used primarily in the automotive mold sector and aerospace industry, and the group employs around 135 people, offering end-to-end coverage of the milling process from machining program definition to finished product.

Average Trading Volume: 1,017,387

Technical Sentiment Signal: Strong Sell

Current Market Cap: €1.79M

Find detailed analytics on FDA stock on TipRanks’ Stock Analysis page.